Musella A

References (3)

Title : Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis - Guadalupi_2024_Neuropharmacol__109940
Author(s) : Guadalupi L , Mandolesi G , Vanni V , Balletta S , Caioli S , Pavlovic A , De Vito F , Fresegna D , Sanna K , Vitiello L , Nencini M , Tartacca A , Mariani F , Rovella V , Schippling S , Ruf I , Collin L , Centonze D , Musella A
Ref : Neuropharmacology , :109940 , 2024
PubMedID: 38570068

Title : miR-142-3p Is a Key Regulator of IL-1beta-Dependent Synaptopathy in Neuroinflammation - Mandolesi_2017_J.Neurosci_37_546
Author(s) : Mandolesi G , De Vito F , Musella A , Gentile A , Bullitta S , Fresegna D , Sepman H , Di Sanza C , Haji N , Mori F , Buttari F , Perlas E , Ciotti MT , Hornstein E , Bozzoni I , Presutti C , Centonze D
Ref : Journal of Neuroscience , 37 :546 , 2017
PubMedID: 28100738

Title : 4-Aminopyridine derivatives with anticholinesterase and antiamnesic activity - Scipione_2008_Bioorg.Med.Chem.Lett_18_309
Author(s) : Scipione L , De Vita D , Musella A , Flammini L , Bertoni S , Barocelli E
Ref : Bioorganic & Medicinal Chemistry Lett , 18 :309 , 2008
PubMedID: 18023348